GRI Bio, Inc. (GRI)
NASDAQ: GRI · Real-Time Price · USD
0.404
+0.021 (5.35%)
At close: Oct 11, 2024, 4:00 PM
0.398
-0.006 (-1.36%)
After-hours: Oct 11, 2024, 7:59 PM EDT
GRI Bio Employees
GRI Bio had 4 employees as of December 31, 2023. The number of employees increased by 3 or 300.00% compared to the previous year.
Employees
4
Change (1Y)
3
Growth (1Y)
300.00%
Revenue / Employee
n/a
Profits / Employee
-$2,069,500
Market Cap
1.18M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 4 | 3 | 300.00% |
| Dec 31, 2022 | 1 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Genprex | 26 |
| Windtree Therapeutics | 20 |
| Seelos Therapeutics | 16 |
| Catheter Precision | 14 |
| Entero Therapeutics | 9 |
| Tivic Health Systems | 9 |
| Revelation Biosciences | 9 |
| PainReform | 7 |
GRI News
- 12 days ago - GRI Bio Granted Japan Patent for Proprietary Natural Killer T (NKT) Cell Modulators for Prevention and Treatment of Inflammatory Conditions - GlobeNewsWire
- 17 days ago - GRI Bio (NASDAQ: GRI) to Participate in a Virtual Investor CEO Connect Segment - GlobeNewsWire
- 5 weeks ago - GRI Bio to Present at the H.C. Wainwright 26th Annual Global Investment Conference - GlobeNewsWire
- 5 weeks ago - GRI Bio to Present at the 2024 European Respiratory Congress - GlobeNewsWire
- 2 months ago - GRI Bio Reports Second Quarter 2024 Financial Results and Provides Corporate Update - GlobeNewsWire
- 3 months ago - GRI Bio (NASDAQ: GRI) to Participate in the Virtual Investor Lunch Break Series - GlobeNewsWire
- 3 months ago - GRI Bio (NASDAQ: GRI) Participates in Virtual Investor “What This Means” Segment - GlobeNewsWire
- 3 months ago - GRI Bio Regains Compliance with Nasdaq - GlobeNewsWire